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We have studied a group of young adult women of 
mean age 23.8 ± 6.5 (SD) years with only acne (A, n = 
46), only hirs utism (H, n = 10), and acne plus hirsutism 
(A+H, n = 19) who sought dermatologic care. We meas-
ured the androgens, total and free testosterone (T), free 
17 ,8-hydroxysteroids (17 -,B), dehydroepiandrosterone 
sulfate (DS), and the androgen precursors 17a-hydroxy-
pregnenolone (17 -Pre g) and 17 a-hydroxyprogesterone 
(17-Prog), as well as testosterone-estrogen binding glob-
ulin in all patients. Plasma hormone levels of the patients 
were compared to those of 23 controls of mean age 25.6 
± 6.6 years who had neither acne nor hirsutism. Mean 
levels of all hormones measured, except 17-Preg, were 
elevated in the women with acne. Fifty-two percent of 
Group A, 60% of Group H, and 63% of Group A+H pa-
tients had at least one abnormal hormone level. The 
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most frequently elevated plasma androgens in all the 
women with acne were: free T 25%, free 17-,B 23%, and 
DS 19%. Total T was high in only 12%. Elevations of 
plasma androgens were present in some women who did 
not have hirsutism or irregular menses. Identification of 
endocrine abnormalities in women with acne may poten-
tially offer an opportunity for hormonal therapy. 
Acne vulgaris is a disorder of sebaceous follicles. It is well 
known that androgens stimulate the pilosebaceous unit; .how-
ever, the clinical role of circulating plasma androgens in the 
pathogenesis of acne has seldom been documented. With the 
advent of new techniques for m easuring free plasma a ndrogens, 
elevations of androgens have been found in a large percentage 
of hirs ute women [1]. Until recently [2,3], most h yperandroge-
nemia in women with acne h as been detected during evaluation 
of hirsutism or menstrual disorders. In this study we have 
measured plasma androgens and their precursors in 75 women 
of mea n age 23.8 ± 6.5 (SD) years who came to a dermatology 
clinic for acne and/or hirsutism. We m easured the androgens, 
total testosterone (total T), free testosterone (free T), free 17,8-
hydroxysteroids (free 17 -,B), dehyru·oepiandrosterone sulfate 
(DS) , a nd the androgen precursors 17a-hydroxypregnenolone 
(17-Preg) and 17a -hyru·oxyprogesterone (17-Prog), as well as 
testosterone-estrogen binding globulin (TEBG) , and compared 
levels in the patients to those in control, age-matched women 
who ha d no significant acne or hirsutism. We have found a 
significant incidence ofhyperandrogenemia in women with acne 
vulgaris. 
MATERIALS AND METHODS 
Patients 
Seventy- five women of mean age 23.8 ± 6.5 (SD) years came to the 
Dermatology Clinic at the Yale New Haven Hospital Medical Center 
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for evaluation and treatment of acne vulgaxis or hirsutism. The contro l 
group consisted of 23 female volunteers of mean age 25.G ± G.G years 
whom we examined and found not to have sign ificant acne or hirsutism. 
The mean ages of the pat ients and controls were not statistically 
different. 
The 75 patients were div ided into 3 gToups (Table I). Group A, n = 
4G, were patients with only acne. Group H , n = 10, were patients with 
only hirsutism. Group A+H, n = 19, were patients who had both acne 
and hirsutism. A total of G5 patients had acne and a total of 29 had 
hirsutism. Medical and menstrual histories were obtained on a ll patients 
and controls. Follicular and lu teal phases were ascertained by history, 
follicu la1· being within 14 days of onset of menses. No patients were 
taking oral cont raceptives or glucocor ticoids. Acne was scored on a 
scale of 1-4 based on the presence of comedones, papules, pustules, or 
cysts present on the face, back, and chest [ 4]. T he presence of more 
than lO comedones, papules, pustules, or any cysts was considered 
significant acne. Most patients had moderate acne. Hirsutism was 
scored on a scale of 1-4 and recorded on preprinted d iagrams outlining 
each of 9 anatomic s ites [1]. Hirsutism was defined in this study as a 
total score of greater than G. Each patient donated a single, random 30-
m! sample of blood which was dxawn into a hepaxinized tube, and the 
sepaxated plasma was stored at -20°C until assayed. Written informed 
consent was obtained from a ll patients, and these studies were approved 
by the Yale University School of Medicine Human Investigation Com-
mittee. 
Hormone Measurements 
Hormone assays were performed in the Pediatric Endocrine Labo-
ratory of the University of Chicago. Plasma total T, free T, free 17-fJ 
(a group measurement including testosterone, dihydxotestosterone 
(DHT), androstenediol, and androstanediol) , DS, 17-Preg, 17-Prog, and 
TEBG were measured by radioimmunoassay and competit ive protein 
binding methods as previously described [5,6). 
Data Analysis 
The upper limi t of normal fo r each androgen was defined as 2 SD 
above the mean value of the 23 control women. Mean values for each 
hormone in each clinical group were compared to the appropriate 
control using Student's /-test adjusted where necessary to account for 
unequal vaxiance among groups. In cases where there was not a normal 
distribution within a group, the nonparametric 2-group Wilcoxon Rank 
Sum test was utilized. Calculations were made on the CLINFO com-
puter of the Yale University Clinical Research Center. 
RESULTS 
Mean Levels of Plasma Androgens (Fig 1} 
The mean level of at least 1 hormone was elevated in every 
study g1·oup. In the 46 patients with only acne, (Group A) or 
the 65 patients with acne ± hirsutism, all steroids measured 
except 17 -Preg were significantly elevated compared to controls. 
Of the 46 women with only acne (Group A), mean levels of total 
T (43 .1 ± 16.0, p < 0.05), free T (7.9 ± 3.4, p < 0.002) , free 17-
{J (44.0 ± 16.9, p < 0.05), and DS (204.5 ± 102.5, p < 0.05) were 
elevated. These data were similar to those found in all 65 
women who had acne. 
Individual Abnormalities of Plasma Androgens (Fig 1) 
Total T was elevated in 13% of Group A, 30% of Group H , 
and 11% of Group A+H. In contrast, free Twas elevated in 
approximately twice as many patients: 24% of Group A, 50% of 
Group H , 26% of Group A+ H. Fig 2 illustrates that 13 of the 75 
women studied had an elevated free T without any abnormality 
of total T. Of the 13 women, 9 had TEBG levels less than 31 
TABLE I. Women. with acne and/or hirsutism who have one or more 
abnormal plasma steroid hormones 
Group No. of Percentage patients of patients 
I. Acne only (A) 24/46 52.2 
II. Hirsutism only (H) 6/10 60.0 
Ill. Acne + hirsutism (A + H) 12/ 19 63.2 
IV. All patients 42/ 75 56.0 
V. All hirsutism (± acne) 18/29 62.1 
VI. All acne (±hirsut ism) 36/65 55.4 
nmol/1 (the lowest value observed in the control group), and 
the other 4 had levels less than 37 nmol/1. 
Fifteen percent of Group A had abnormal 17 -{J. Free 17 -{Js 
were more frequently elevated in the hirsute patients-high in 
30% of Group H and 34.5% of all 29 hirsute patients. DS was 
elevated in 12/65 (18.5%) of the women with acne. 
Follicular phase levels of 17-Prog were high in 4/13 (31%) of 
t he acne only patients, 2/3 (67%) of the hirsute only patients, 
and 4/10 (40%) of t he patients with both acne and hirsutism. 
Luteal phase levels of 17-Prog were rarely elevated. 17-Preg 
had a wide scatter even in control subjects and was not often 
abnormal in the patients. There was no statistical difference 
between follicular and luteal levels of any hormones other than 
17-Prog measured in this study. 
The most frequently abnormal androgen was free T which 
was elevated in 16/65 (24.6%) of acne patients. Free 17 -{J was 
elevated in 14/65 (23%) and DS was elevated in 12/ 65 (18.5%). 
Of the 65 women with acne, measurement of free T alone 
showed that 25% of the patients were hyperandrogenic; addition 
of DS raised the ascertainment to 33%, and addition of free 17-
{J raised it to 43%. There were 11/65 (17%) of patients who had 
abnormalit ies only of the androgen precursors 17-Preg and 17-
Prog. 
If one considers the lower limit of normal of TEBG to be 2 
SD below the mean (TEBG = l 7 nmol/1) then there were very 
few patients with low TEBG levels. However, if the cutoff for 
normal is set at the observed range of the normal controls 
(TEBG < 31 nmol/1) then 14/ 46 acne only patients (30.4%) and 
22/65 acne and hirsutism patients (33.8%) had significantly low 
levels of plasma TEBG. 
Overall, more than half of t he patients had at least 1 abnormal 
steroid hormone (Table I). The number of plasma abnormalities 
per patient varied: 16 women h ad 1 abnormality, 13 had 2 
abnormalities, 9 had 3 abnormalities, and 4 had 4 abnormalities. 
Of the latter 4 women, 1 had acne, 1 had hirsutism, and 2 had 
both. Two of them had irregular menses. There was no in-
creased incidence of elevated plasma hormone levels in patients 
with a history of menstrual irregularities. Of the 65 women with 
acne, 21 patients had irregular menses and 13 (62%) of t hem 
had abnormal levels; but 44 patients had normal menses and 23 
(52%) of t hem also had high hormone levels. The difference 
between the two g1·oups was not significant. There was a similar 
distribution in the g1·oup with acne only and in the whole group. 
There was no significant correlation of androgen levels with 
age, severity of acne, or severity of hirsutism as determined by 
linear regression analysis. 
DISCUSSION 
The ability of androgens to stimulate sebaceous glands is well 
known, but the importance of circulating plasma androgens 
(such as T, 17 -{J, and DS) and precursor substrates (such as 17-
Preg and 17-Pro g) in the pathogenesis of acne vulgaris has not 
been well substantiated. The advent of specific and sensitive 
radioimmunoassays for free and multiple androgens and their 
precmsors permits a new evaluation of the significance of 
elevated plasma androgens in acne. We have found that more 
than half of a g1·oup of young adult women whose primary 
complaint was acne had elevated androgens or androgen pre-
cursors. Hyperandrogenemia in these patients was diagnosed 
on the basis of measurement of DS, free plasma testosterone, 
and other 17 {J- hydroxysteroids. 
In the past no consistent abnormalities of urinary 17 ketoste-
roids or testosterone have been found in patients with acne 
[2, 7-10]. Elevated urinary 5a-androstanediol was reported in 10 
women with acne [11). Plasma levels of total T have been 
reported to be both normal [9,11,12,13] and elevated [2,14,15, *] 
* Marynick SP, Chak111akjian ZH, McCaffree D, H erndon JH Jr: 
Severe cystic acne: a spectrum of treatable endocrinopathies. Abstract 
457, presented at the 1981 Annual Meeting of the Endocrine Society in 
Cincinnati, Ohio. 
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FIG 1. Plasma levels of the androgens, total testosterone (total T) , free testosterone (free T) , free 17/J-hydroxystero ids (free 17{3), and 
dehydroepiandrosterone sulfate (DS) ; the androgen precursors 17a-hydroxyprogesterone (I 7-Prog) in fo llicular (F) and lu teal (L) phases of the 
menstrual cycle, and 17a-hydroxypregnenolone (17 Preg); and testosterone-estrogen binding globulin (TEBG) in 23 control women (C) , 46 
women with acne (A), 10 women with hirsut ism (H), and 19 women with acne and hirsutism (A+H). Dash ed line indicates limi t of normal, bar 
. indicates mean, and p values relate the mean levels of patients to the controls. Mean levels of aU steroid hormones except 17 Preg are elevated 
in acne patients. 
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FIG 2. Plasma free testosterone (free T) and total testosterone 
(total T) in 75 women with acne and/ or hirsutism. Dashed lines 
indicate upper limit of normal. Open. circles represent 13 patients with 
normal levels of total T and elevated levels of free T. These women 
had TEBG levels less than 37 nmol/1. Androgen abnormalities would 
not have been detected if only T had been measured in these 13 women. 
in patients with acne. In most studies where T was elevated, 
patients were ascertained because of gynecologic complaints or 
severe refractory cystic acne. There have been few studies of 
plasma free T in patients with acne. Lawrence et al [16] found 
46% of women with severe acne and 89% with acne and hirsu-
tism had elevated "derived" free T levels. Walker et al found 
no elevation of free Tin 18 females with acne [17]. Free 17-(3 
was found to be high when studied in a few females with acne 
[18]. Androstenedione has not been useful [15]. Recently there 
have been reports of elevated dehydroepiandrosterone (D) and 
DS in patients with refractory acne or gynecologic abnormali-
ties [15,17, *] TEBG has been found to be both low [13,16,17] 
and normal [18, *] in women who had acne and were hyperan-
drogenic. 
We found that more than 40% of our patients had elevated 
plasma androgens and more than half had at least 1 abnormal 
plasma hormone value when androgen precursors were in-
cluded. We compared our patients to a group of women who 
were selected because they had neither acne nor hirsutism. The 
use of a nonselected "control" population in which individuals 
with acne are not excluded may result in significantly higher 
"control" values for am:!Togens and underdetection of patients 
with hyperandrogenemia. Thus it is difficult to interpret pre-
vious studies in which the control group was not selected. 
We found that free Twas elevated in twice as many patients 
as total T. In 13 women free T was high when total T was 
normal. Their hormone abnormality would have been missed 
if only total T were measured. Most of these 13 had TEBG 
levels lower than the observed range of the control women to 
account for the discrepancy. Overall, a quarter of the women 
with acne had high plasma free T. T circulates bound primarily 
to TEBG, but only the free or unbound fraction seems to be 
biologically active. Low TEBG increases the fraction ofT that 
is free and thus explains why total T may be unremarkable 
when free Tis elevated. Similarly, measurements of free 17-(3 
increased the ascertainment of hyperandrogenemia. 
Our findings of high androgens in acne are similar to findings 
in studies of hirsutism [1,19]. In our study we found that a 
significant number of women who had acne without hirsutism 
also had abnormal androgens. The absence of hirsutism in 
women with acne does not therefore assure normal androgen 
levels. This discrepancy may be accounted for by individual 
sensitivity to stimulation of hair growth or by the duration of 
hyperandrogenemia. 
Thirty-eight percent (10/26) of our patients had elevated 
levels of 17-Prog in the follicular (F) phase of the menstrual 
cycle. Luteal (L) phase levels were not different from controls. 
The patients with high 17-Prog (F) may have partial blocks in 
adrenal 21-hydroxylase, the most common form of congenital 
adrenal hyperplasia (CAH) as 17-Prog is the immediate sub-
strate for 21-hydroxylase. Another possible explanation is that 
17-Prog may be of ovarian origin, and its elevation in the F 
phase of the menstrual cycle may be related to the well-known 
cyclic flare ·of acne which occurs in the second half of the 
menstrual cycle. It is possible that sebaceous glands stimulated 
in the F phase with 17-Prog, progesterone, or more androgenic 
metabolites [20] may induce acne lesions in the ensuing L phase 
of the menstrual cycle. Further studies of hormone profiles at 
various times in the menstrual cycle are needed to test this 
hypothesis. 
The source of abnormal plasma androgens in these women is 
unknown. Androgens are not only secreted by the adrenal and 
the ovary but are produced from precursor hormones by me-
tabolism in the skin [21]. In this manner high circulating levels 
of weakly androgenic precursors may be locally metabolized to 
more potent androgens. Testosterone is derived from the ad-
renal, ovary, and from the conversion of precursors in locatim:s 
such as fat, liver, and skin. DS is a good marker for adrenal 
androgen production as it is normally produced primarily in the 
adrenal [21]. Nineteen percent of our patients had elevated 
levels ofDS. Patients with complete forms of CAH may develop 
acne when they are in poor control. Recently, mild CAH (also 
called partial, late onset, adult, or acquu·ed CAH) with mild 
defects in 11- or 21-hydroxylase [22-28] or 3{3-hydroxysteroid 
dehydrogenase [29,30] have been identified in women with 
evidence of high androgens such as menstrual dysfunction, 
hirsut ism, and acne. Although only a small fraction of patients 
who come to a dermatologist because of acne may have mild 
CAH, the disorder is so amenable to treatment with low doses 
of glucocorticoids that it is worthwhile to identify them. ACTH 
stimulation tests or empirical trials of glucocorticoid suppres-
sion may be warranted in patients with high levels of DS. 
We found that patients with acne and a «normal" menstrual 
history could also be hyperandrogenic, illustrating that occult 
ovarian or adrenal dysfunction may be present. Until now it 
had been assumed that end organ metabolism of androgens 
accounted entirely for the clinical expressions of acne and 
hirsutism. Documentation of this hypothesis has been difficult 
[31-33]. Our findings of elevated plasma androgens emphasize, 
in addition, that a hormonal basis of acne is frequent. Such 
cases may be amenable to hormone therapy. 
In conclusion, we have demonstrated that there are abnor-
malities of plasma androgens in a significant number of adult 
women with acne vulgaris. Our patients represent a selected 
population because of persistence or appearance of acne in the 
third and fourth decades. Most of om patients were young 
women in their twenties and thirties; we do not have informa-
tion on plasma androgens in adolescents with acne. Although 
acne alone was the reason that most of the women entered this 
study, one-third of them had menstrual irregularities and one-
third were hirsute. We would emphasize, however, that half of 
the acne patients who had normal mensb·ual histories had 
elevated plasma androgens, and that patients with acne alone 
(A) had an incidence of elevated androgens similar to those 
with acne plus hirsutism (A+ H) . Measurements of plasma free 
T (and other free androgens such as 17 -{3) as well as DS in 
women with late onset or persistent acne may identify endocrine 
abnormalities potentially amenable. to hormonal treatment. 
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